Development of a protection method to prevent spinal cord ischemia by promoting spinal collateral circulation with proangiogenic cytokine-inducer.
Project/Area Number |
15K10243
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Cardiovascular surgery
|
Research Institution | Osaka University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
倉谷 徹 大阪大学, 医学系研究科, 寄附講座教授 (90448035)
鳥飼 慶 大阪大学, 医学系研究科, 講師 (70364792)
|
Research Collaborator |
MIYAGAWA Shigeru
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 大動脈瘤 / 脊髄虚血 / 再灌流障害 / 胸腹部大動脈瘤 / 血管新生 |
Outline of Final Research Achievements |
The objective of this study is to develop a protection method to prevent spinal cord ischemia by promoting spinal collateral circulation with proangiogenic cytokine-inducer (ONO-1301). We found that intravenously injected ONO-1301 incorporated liposome-based nanoparticle was selectively accumulated in ischemic area. Histologically, gene expression of proangiogenic cytokines of hepatocyte growth factor or angiopoietin-1 in the ischemic area were significantly higher and CD31-positive capillaries in the ischemic area were significantly greater in the ONO-1301 group.
|
Report
(4 results)
Research Products
(2 results)